Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 09, 2020 07:00 ET | Source: SoniVie

SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System for Renal Artery Denervation

- SoniVie Acquires New Intellectual Property and Other Assets from Cardiosonic Moving TIVUS into New Therapeutic Areas Beyond Pulmonary Hypertension - TEL AVIV, Israel, Dec. 09, 2020 (GLOBE...
October 13, 2020 07:00 ET | Source: SoniVie

SoniVie Receives IDE Approval for its Pivotal Study for the TIVUS System to Treat Patients with Pulmonary Arterial Hypertension (PAH)

- International study designed to build on positive 12-month data from TROPHY1 demonstrating improvement in multiple clinical endpoints and no serious procedure-related adverse events- TEL...